THE_AGP_CLINICAL_ACADEMY_ - Accounts


Company Registration No. 9199669 (England and Wales)
THE AGP CLINICAL ACADEMY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
PAGES FOR FILING WITH REGISTRAR
THE AGP CLINICAL ACADEMY LTD
CONTENTS
Page
Accountants' report
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 7
THE AGP CLINICAL ACADEMY LTD
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF THE AGP CLINICAL ACADEMY LTD FOR THE YEAR ENDED 31 DECEMBER 2019
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of The AGP Clinical Academy Ltd for the year ended 31 December 2019 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

This report is made solely to the Board of Directors of The AGP Clinical Academy Ltd, as a body, in accordance with the terms of our engagement letter dated 26 April 2018. Our work has been undertaken solely to prepare for your approval the financial statements of The AGP Clinical Academy Ltd and state those matters that we have agreed to state to the Board of Directors of The AGP Clinical Academy Ltd, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than The AGP Clinical Academy Ltd and its Board of Directors as a body, for our work or for this report.

It is your duty to ensure that The AGP Clinical Academy Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of The AGP Clinical Academy Ltd. You consider that The AGP Clinical Academy Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of The AGP Clinical Academy Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Azets
14 September 2020
Fareham House
69 High Street
Fareham
Hampshire
PO16 7BB
THE AGP CLINICAL ACADEMY LTD
BALANCE SHEET
AS AT
31 DECEMBER 2019
31 December 2019
- 2 -
2019
2018
Notes
£
£
£
£
Fixed assets
Tangible assets
3
3,423
3,769
Current assets
Debtors
4
504
51,712
Cash at bank and in hand
18,578
-
19,082
51,712
Creditors: amounts falling due within one year
5
(1,339)
(32,662)
Net current assets
17,743
19,050
Total assets less current liabilities
21,166
22,819
Provisions for liabilities
(650)
(716)
Net assets
20,516
22,103
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
20,416
22,003
Total equity
20,516
22,103

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

THE AGP CLINICAL ACADEMY LTD
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2019
31 December 2019
2019
2018
Notes
£
£
£
£
- 3 -
The financial statements were approved by the board of directors and authorised for issue on 14 September 2020 and are signed on its behalf by:
Dr. I Cranston
Director
Company Registration No. 9199669
THE AGP CLINICAL ACADEMY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
- 4 -
1
Accounting policies
Company information

The AGP Clinical Academy Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Fareham House, 69 High Street, Fareham, Hampshire, England, PO16 7BB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

THE AGP CLINICAL ACADEMY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 5 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

THE AGP CLINICAL ACADEMY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2019
2018
Number
Number
Total
2
2
THE AGP CLINICAL ACADEMY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 7 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2019
3,769
Additions
978
At 31 December 2019
4,747
Depreciation and impairment
At 1 January 2019
-
Depreciation charged in the year
1,324
At 31 December 2019
1,324
Carrying amount
At 31 December 2019
3,423
At 31 December 2018
3,769
4
Debtors
2019
2018
Amounts falling due within one year:
£
£
Trade debtors
-
46,460
Other debtors
504
5,252
504
51,712
5
Creditors: amounts falling due within one year
2019
2018
£
£
Bank loans and overdrafts
-
26,917
Corporation tax
-
4,445
Other creditors
1,339
1,300
1,339
32,662
2019-12-312019-01-01false14 September 2020CCH SoftwareCCH Accounts Production 2020.200No description of principal activityDr I CranstonProfessor R Mazze91996692019-01-012019-12-3191996692019-12-3191996692018-12-319199669core:OtherPropertyPlantEquipment2019-12-319199669core:OtherPropertyPlantEquipment2018-12-319199669core:CurrentFinancialInstrumentscore:WithinOneYear2019-12-319199669core:CurrentFinancialInstrumentscore:WithinOneYear2018-12-319199669core:ShareCapital2019-12-319199669core:ShareCapital2018-12-319199669core:RetainedEarningsAccumulatedLosses2019-12-319199669core:RetainedEarningsAccumulatedLosses2018-12-319199669bus:Director12019-01-012019-12-319199669core:ComputerEquipment2019-01-012019-12-3191996692018-01-012018-12-319199669core:OtherPropertyPlantEquipment2018-12-319199669core:OtherPropertyPlantEquipment2019-01-012019-12-319199669core:CurrentFinancialInstruments2018-12-319199669core:WithinOneYear2019-12-319199669core:WithinOneYear2018-12-319199669core:CurrentFinancialInstruments2019-12-319199669bus:PrivateLimitedCompanyLtd2019-01-012019-12-319199669bus:SmallCompaniesRegimeForAccounts2019-01-012019-12-319199669bus:FRS1022019-01-012019-12-319199669bus:AuditExemptWithAccountantsReport2019-01-012019-12-319199669bus:Director22019-01-012019-12-319199669bus:FullAccounts2019-01-012019-12-31xbrli:purexbrli:sharesiso4217:GBP